Multidrug chemotherapy in the treatment of non-elderly patients with hormone-refractory prostatic carcinoma. A phase II study

European Urology

Volumn 29, Issue 4, 1996, Pages 434-438

  Veronesi, A ^a   Lo Re, G ^a   Foladore, S ^a   Merlo, A ^a   Giuliotto, N ^a   Talamini, R ^a   Monfardini, S ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Hormone refractoriness, prostate cancer; Multidrug chemotherapy; Prostate cancer, 'non elderly' patients

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; ESTRAMUSTINE PHOSPHATE; HORMONE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HAIR DISEASE; HEART INFARCTION; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; MASTALGIA; MYALGIA; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; REMISSION; STOMATITIS;

EID: 0029883252     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000473792     Document Type: Article

References (0)